|
We are building a portfolio of compounds that have first-in-class and best-in-class potential through our own discovery research and clinical development initiatives.
more >
|
 |
08/28/08
CORRECTING and REPLACING Exelixis Announces September 4 Webcast of Presentation at BioCentury's NewsMakers in the Biotech Industry Conference
08/28/08
Exelixis Announces September 4 Webcast of Presentation at BioCentury's NewsMakers in the Biotech Industry Conference
|
|
Seven abstracts featuring Exelixis compounds were presented at ASCO's annual meeting from May 30 to June 3. Click below for an overview of some of the key data that were presented.
more >
Information not available at this time
|
|
Looking for a career at Exelixis? We are looking for people to join us as we turn our vision into reality.
more >
NASDAQ: EXEL
Sep 5 2008 4:00PM
PRICE: 5.64 -0.07
VOLUME: 1462851 SHARES
20 minute delay
more >
|
